13F HOLDINGS REPORT
Foresite Capital Management VI LLC
Quarter ended Q2 2025 · Filed August 12, 2025 · Accession 0001104659-25-076821
Total Value
$177.9M
Positions
20
Other Managers
0
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG Oncology, Inc. | CGON | 2,221,474 | $57.8M | 32.47% |
| 2 | Centessa Pharmaceuticals Inc | CNTA | 1,253,379 | $16.5M | 9.26% |
| 3 | Akero Therapeutics Inc | 00973Y108 | 244,900 | $13.1M | 7.35% |
| 4 | Alumis Inc | ALMS | 4,247,670 | $12.7M | 7.16% |
| 5 | Rapt Therapeutics Inc | 75382E208 | 1,562,500 | $12.5M | 7.03% |
| 6 | Bicara Therapeutics Inc | BCAX | 949,260 | $8.8M | 4.96% |
| 7 | Edgewise Therapeutics Inc | EWTX | 585,000 | $7.7M | 4.31% |
| 8 | Hinge Health Inc | HNGE | 135,000 | $7.0M | 3.93% |
| 9 | Corvus Pharmaceuticals Inc | CRVS | 1,731,233 | $6.9M | 3.89% |
| 10 | Kymera Therapeutics Inc | KYMR | 146,332 | $6.4M | 3.59% |
| 11 | Verastem Inc | VSTM | 1,276,520 | $5.3M | 2.98% |
| 12 | Xenon Pharmaceuticals Inc | XENE | 160,000 | $5.0M | 2.82% |
| 13 | Cullinan Therapeutics Inc | CGEM | 594,025 | $4.5M | 2.51% |
| 14 | Structure Therapeutics Inc | GPCR | 210,000 | $4.4M | 2.45% |
| 15 | Allogene Therapeutics Inc | ALLO | 2,875,357 | $3.2M | 1.83% |
| 16 | Ideaya Biosciences Inc | IDYA | 144,468 | $3.0M | 1.71% |
| 17 | Avidity Biosciences Inc | 05370A108 | 40,000 | $1.1M | 0.64% |
| 18 | Spyre Therapeutics Inc | SYRE | 70,000 | $1.0M | 0.59% |
| 19 | Casi Pharmaceuticals Inc | CASIF | 787,121 | $928,803 | 0.52% |
| 20 | Viridian Therapeutics, Inc | VRDN | 1,974 | $27,597 | 0.02% |